Clinical Value of a Rapid Fully Automated Thyroid Autoantibody Assay in the Diagnosis and Management of Graves Disease
Automated Thyroid Autoantibody Assay
Vol. 7 No. 1 : 2012 (24-31)
Abstract
The most common cause of hyperthyroidism is Graves disease (GD) which is characterised by the presence of autoantibodies which binds to the TSH receptor (TRAb). Recently, a rapid, fully automated electrochemiluminescent immunoassay ElecsysAnti-TSHR for detection of autoantibodies to TSH receptor was made available for routine clinical use. The objective of this study is to evaluate this assay and to determine the sensitivity, specificity and cut-off value. Interassay and total imprecision (CV) were determined at 3.78-7.02 IU/L and 13.5-21.2 IU/L respectively. A total of 124 samples which comprised of 46 GD, seven Hashimoto thyroiditis (HD), 11 non autoimmune nodular goitre (NAG), 2 thyroid cancers (Ca) and 58 normal controls were retrospectively analysed to determine the sensitivity, specificity and cut-off value. Inter-assay CV’s were 2.4% at a concentration of 3.90 IU/L (range: 3.78-7.02 IU/l) and 0.8% at 20.80 IU/L (range:13.5-21.2 IU/l). Total imprecision was 3.8% at a concentration of 3.80 IU/L (range:13.5-21.2 IU/l) and 1.0% at 20.8 IU/L (range:13.5-21.2 IU/l). The ROC analysis of patients with GD, other thyroid disorders and normal controls revealed that the highest sensitivity (94%) and specificity (98%) were seen at cut-off value of 1.69 IU/L. Positive predictive value (PPV) and negative predictive value (NPV) was 95% and 94% respectively. At this derived cut-off value of 1.69 IU/L, we found that the sensitivity of TRAb positivity within the group of 29 newly diagnosed GD patients was 94%. Our results demonstrate that this fully automated assay with testing time of 27 minutes has high sensitivity in detecting GD and high specificity for discriminating other thyroid disease and represent major improvement in the diagnosis and management of patients with thyroid diseases.
Keywords :
Graves disease,
reproducibility,
sensitivity,
specificity,
TSH Receptor,
Correspondance Address
Dr. Hanita Othman, Department of Diagnostic Laboratory Services, Universiti Kebangsaan Malaysia Medical Centre, Jalan Yaakob Latif, Bandar Tun Razak, Cheras,56000, Kuala Lumpur . Tel: 603-91455449 Fax: 603-91456579. Email: drhanita@ppukm.ukm.edu.my
References
Bolton, J., Sanders, J., Oda, Y., Chapman, C., Konno, R., Furmaniak, J., Rees Smith, B. 1999. Measurement of thyroid-stimulating hormone receptor autoantibodies by ELISA. Clin Chem 45(12): 2285-2289.
Hermsen, D., Broecker-Preuss, M., Casati, M., Mas, J.C., Eckstein, A., Gassner, D., van Helden, J., Inomata, K., Jarausch, J., Kratzsch, J., Mann, K., Miyazaki, N., Navarro Moreno, M.A., Murakami, T., Roth, H.J., Noh, J.Y., Scherbaum, W.A., Schott, M. 2009. Technical evaluation of the first fully automated assay for the detection of TSH receptor autoantibodies. Clin Chem Acta 401(1-2):84-89.
Kamijo, K. 2003. TSH-receptor antibody measurement in patients with various thyrotoxicosis and Hashimoto thyroiditis: a comparison of two steps assay using porcine TSH-receptor and human recombinant TSH receptor. Endocr J 50(1):113-116.
Kamijo, K. 2007. TSH-receptor antibody determined by first, second and third generation assay. Endocr J 54(4): 619-624.
Liu, C., Hermsen, D., Domberg, J. 2008. Comparison of M22-based ELISA and human-TSH-receptor-based luminescencence assay for the measurement of thyrotropin receptor antibodies in patients with thyroid diseases. Horm Metab Res 40(7):479-483.
Morgenthaler,N.G 1999. New assay systems for thyrotropin receptor antibodies. Curr Opin Endocrinol Diabetes 6:251-260.
Sanders, J., Jeffreys, J., Depraetere, H., Richards, T., Evans, M., Kiddie, A., Brereton, K., Groenen, M., Oda, Y., Furmaniak, J., Rees Smith, B. 2002. Thyroid stimulating monoclonal antibodies. Thyroid 12(12):1043-1050.
Saravanan, P., Dayan, C.M. 2001. Thyroid autoantibodies. Endocrinol Metab Clin North Am 30(2):315-337.
Schott, M., Hermsen, D., Martina, B.P., Marco, C.J. 2009. Clinical value of first automated TSH receptor autoantibody assay for the diagnosis of Graves disease: an international multicentre trial. Clin Endocrinol 63 enclosure 6:1-8.
Schott, M., Scherbaum, W.A., Morgenthaler, N.G. 2005. Thyrothropin receptor autoantibodies in Graves disease. Trends Endocrinol Metab 16(5):243-248
Smith, B.R., Bolton, J., Young, S., Collyer, A., Weeden, A., Bradbury, J., Weightman, D., Perros, P., Sanders, J., Furmaniak, J. 2005 A new assay for thyrotropin receptor autoantibodies. Thyroid 14(10):830-835.
Smith, B.R., Sanders, J., Furmaniak, J. 2007. TSH receptor antibodies. Thyroid 17(10):923-38
Weetman, A.P. 2000. Graves’ Disease. N Engl J Med 343(17): 1236- 48.
